These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 24771609)

  • 1. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial.
    Mentz RJ; Cotter G; Cleland JG; Stevens SR; Chiswell K; Davison BA; Teerlink JR; Metra M; Voors AA; Grinfeld L; Ruda M; Mareev V; Lotan C; Bloomfield DM; Fiuzat M; Givertz MM; Ponikowski P; Massie BM; O'Connor CM
    Eur J Heart Fail; 2014 Jun; 16(6):614-24. PubMed ID: 24771609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
    Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
    Ter Maaten JM; Valente MA; Damman K; Cleland JG; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Bloomfield DM; Cotter G; Davison B; Subacius H; van Veldhuisen DJ; van der Meer P; Hillege HL; Gheorghiade M; Voors AA
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27266853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
    Kristensen SL; Køber L; Jhund PS; Solomon SD; Kjekshus J; McKelvie RS; Zile MR; Granger CB; Wikstrand J; Komajda M; Carson PE; Pfeffer MA; Swedberg K; Wedel H; Yusuf S; McMurray JJ
    Circulation; 2015 Jan; 131(1):43-53. PubMed ID: 25406306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial.
    Metra M; Mentz RJ; Chiswell K; Bloomfield DM; Cleland JG; Cotter G; Davison BA; Dittrich HC; Fiuzat M; Givertz MM; Lazzarini V; Mansoor GA; Massie BM; Ponikowski P; Teerlink JR; Voors AA; O'Connor CM
    Eur J Heart Fail; 2015 Jan; 17(1):109-18. PubMed ID: 25431336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program.
    Blair JE; Zannad F; Konstam MA; Cook T; Traver B; Burnett JC; Grinfeld L; Krasa H; Maggioni AP; Orlandi C; Swedberg K; Udelson JE; Zimmer C; Gheorghiade M;
    J Am Coll Cardiol; 2008 Nov; 52(20):1640-8. PubMed ID: 18992654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.
    Massie BM; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Weatherley BD; Cleland JG; Givertz MM; Voors A; DeLucca P; Mansoor GA; Salerno CM; Bloomfield DM; Dittrich HC;
    N Engl J Med; 2010 Oct; 363(15):1419-28. PubMed ID: 20925544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial.
    Khan H; Greene SJ; Fonarow GC; Kalogeropoulos AP; Ambrosy AP; Maggioni AP; Zannad F; Konstam MA; Swedberg K; Yancy CW; Gheorghiade M; Butler J;
    Eur J Heart Fail; 2015 Oct; 17(10):1022-31. PubMed ID: 25960401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS.
    Bhatt AS; Luo N; Solomon N; Pagidipati NJ; Ambrosio G; Green JB; McGuire DK; Standl E; Cornel JH; Halvorsen S; Lopes RD; White HD; Holman RR; Peterson ED; Mentz RJ;
    Am Heart J; 2019 Dec; 218():57-65. PubMed ID: 31707329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure.
    Filippatos G; Angermann CE; Cleland JGF; Lam CSP; Dahlström U; Dickstein K; Ertl G; Hassanein M; Hart KW; Lindsell CJ; Perrone SV; Guerin T; Ghadanfar M; Schweizer A; Obergfell A; Collins SP
    JAMA Cardiol; 2020 Apr; 5(4):401-410. PubMed ID: 31913404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies.
    Davison BA; Metra M; Cotter G; Massie BM; Cleland JGF; Dittrich HC; Edwards C; Filippatos G; Givertz MM; Greenberg B; Ponikowski P; Voors AA; O'Connor CM; Teerlink JR;
    JACC Heart Fail; 2015 May; 3(5):395-403. PubMed ID: 25951761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study.
    Cleland JG; Chiswell K; Teerlink JR; Stevens S; Fiuzat M; Givertz MM; Davison BA; Mansoor GA; Ponikowski P; Voors AA; Cotter G; Metra M; Massie BM; O'Connor CM
    Circ Heart Fail; 2014 Jan; 7(1):76-87. PubMed ID: 24281134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial.
    Greene SJ; Fonarow GC; Solomon SD; Subacius H; Maggioni AP; Böhm M; Lewis EF; Zannad F; Gheorghiade M;
    Eur J Heart Fail; 2015 Jun; 17(6):591-600. PubMed ID: 25930208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial.
    Demissei BG; Postmus D; Liu LCY; Cleland JG; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Davison BA; Edwards C; Givertz MM; Bloomfield DM; Dittrich HC; Voors AA; Hillege HL
    Int J Cardiol; 2016 Nov; 223():967-975. PubMed ID: 27589047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial.
    Butler J; Subacius H; Vaduganathan M; Fonarow GC; Ambrosy AP; Konstam MA; Maggioni A; Mentz RJ; Swedberg K; Zannad F; Gheorghiade M;
    J Am Coll Cardiol; 2013 Feb; 61(5):571-9. PubMed ID: 23246389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure.
    Ter Maaten JM; Damman K; Hanberg JS; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Cotter G; Davison B; Cleland JG; Bloomfield DM; Hillege HL; van Veldhuisen DJ; Voors AA; Testani JM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27507112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.
    Metra M; O'Connor CM; Davison BA; Cleland JG; Ponikowski P; Teerlink JR; Voors AA; Givertz MM; Mansoor GA; Bloomfield DM; Jia G; DeLucca P; Massie B; Dittrich H; Cotter G
    Eur Heart J; 2011 Jun; 32(12):1519-34. PubMed ID: 21388992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer-than-average length of stay in acute heart failure : Determinants and outcomes.
    Omar HR; Guglin M
    Herz; 2018 Mar; 43(2):131-139. PubMed ID: 28168428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
    Gheorghiade M; Böhm M; Greene SJ; Fonarow GC; Lewis EF; Zannad F; Solomon SD; Baschiera F; Botha J; Hua TA; Gimpelewicz CR; Jaumont X; Lesogor A; Maggioni AP;
    JAMA; 2013 Mar; 309(11):1125-35. PubMed ID: 23478743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
    Voors AA; Davison BA; Teerlink JR; Felker GM; Cotter G; Filippatos G; Greenberg BH; Pang PS; Levin B; Hua TA; Severin T; Ponikowski P; Metra M;
    Eur J Heart Fail; 2014 Nov; 16(11):1230-40. PubMed ID: 25287144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.